Tag: remission

Adding ascorbic acid to arsenic trioxide produces limited benefit in patients with acute myeloid leukemia excluding acute promyelocytic leukemia

This phase II clinical trial evaluated the efficacy and safety of combining arsenic trioxide (ATO) with ascorbic acid (AA) in patients with acute myeloid leukemia (AML) excluding acute promyelocytic leukemia (APL). Eleven patients, including elderly individuals unfit for intensive chemotherapy, received intravenous ATO (0.25 mg/kg/day) and AA (1 g/day) for

Read More »

Methylene Blue: Revisited

This systematic review evaluates the safety and efficacy of 5-aminosalicylic acid (5-ASA) for treating ulcerative colitis (UC), finding it effective in both inducing and maintaining remission in UC patients. The study showed remission rates of 50-60% depending on the dosage, with minimal side effects such as headaches and gastrointestinal disturbances.

Read More »